CytoSorbents Corporation (CTSO)

[andy55q]

Testimonials
Professor John Kellum, University of Pittsburgh, US

“I think that this particular technology is unique. One of the unique properties is that it is more biocompatible than typical adsorbents…”

Dr. Albert Grootendorst, University of Rotterdam, Netherlands

“The effectiveness of CytoSorb is based on the removal of mediators of sepsis that cause renal failure, liver failure, ARDS, etc. So it is not a symptomatic therapy, like we used to do. Now, we try to treat the cause of the ARDS and of the renal failure…”

Professor Zsolt Molnar, University of Szeged, Hungary

“My view on the future of CytoSorb therapy is that it will, I think, go towards a so called individualized treatment. […] Some patients will need it for 12 hours, and others may need it for 72 hours…”

http://cytosorb-therapy.com/the-adsober/testimonials/